Ian Clark

Biography

Ian is currently serving as an Operating Partner within Clarus Ventures and most recently served as Chief Executive Officer of Genentech and as Head of Roche's North American Commercial Operations. From 2003 to 2010 he held the positions of Head of Global Product Strategy and Chief Marketing Officer, Executive Vice President – Commercial Operations and Senior Vice President and General Manager – BioOncology at Genentech. Prior to joining Genentech, he served as general manager of Novartis Canada, where he oversaw all of the company's operations, and as Chief Operating Officer for Novartis United Kingdom. Ian serves on the boards of Agios Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., and Shire plc. He was recently a member of the Kite Pharma board until its acquisition by Gilead Inc. Since 2009, he has served on the boards of directors of the Biotechnology Industry Organization (BIO), the Gladstone Foundation, and the Federal Reserve Bank of San Francisco's Economic Advisory Council. He is an Advisor to the Institute of Life Sciences at Southampton University in the UK. Ian received a Bachelor of Science Degree and an Honorary Doctorate in Biological Sciences from Southampton University in the United Kingdom. Ian is currently serving as an Operating Partner within Clarus Ventures and most recently served as Chief Executive Officer of Genentech and as Head of Roche's North American Commercial Operations. From 2003 to 2010 he held the positions of Head of Global Product Strategy and Chief Marketing Officer, Executive Vice President – Commercial Operations and Senior Vice President and General Manager – BioOncology at Genentech. Prior to joining Genentech, he served as general manager of Novartis Canada, where he oversaw all of the company's operations, and as Chief Operating Officer for Novartis United Kingdom. Ian serves on the boards of Agios Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., and Shire plc. He was recently a member of the Kite Pharma board until its acquisition by Gilead Inc. Since 2009, he has served on the boards of directors of the Biotechnology Industry Organization (BIO), the Gladstone Foundation, and the Federal Reserve Bank of San Francisco's Economic Advisory Council. He is an Advisor to the Institute of Life Sciences at Southampton University in the UK. Ian received a Bachelor of Science Degree and an Honorary Doctorate in Biological Sciences from Southampton University in the United Kingdom.

Research Interest

Biochemistry